Aoife Brennan Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Aoife Brennan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Aoife Brennan. Aoife Brennan is a Director in FIBROGEN INC ($FGEN) and a Director in Ra Pharmaceuticals, Inc. ($RARX) and a Chief Medical Officer in SYNLOGIC, INC. ($MIRN) and a Interim President and CEO in SYNLOGIC, INC. ($SYBX) and a President and CEO in SYNLOGIC, INC. ($SYBX) and a See Remarks in SYNLOGIC, INC. ($SYBX).
Address: C/O SYNLOGIC, INC. 200 SIDNEY STREET, SUITE 320 CAMBRIDGE 02139 MA
Companies in which Aoife Brennan is an Insider
FIBROGEN INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Aoife Brennan: Director
Holdings: 3,914 shares
Current Value: $93,545
Latest Transaction: Aug 07 2020
$FGEN Market Capitalization: $1.47B
$FGEN Previous Close: $23.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ra Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Aoife Brennan: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNLOGIC, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Aoife Brennan: See Remarks, Interim President and CEO, Chief Medical Officer
Holdings: 177,317 shares
Current Value: $390,097
Latest Transaction: Mar 12 2021
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Aoife Brennan
Sentiment: All, FGEN, RARX, SYBX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 3.50 | 285,000 | 997,500 | 285,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 3.50 | 285,000 | 997,500 | 285,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 71,250 | 0 | 177,317 | 106.1 K to 177.3 K (+67.17 %) |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 71,250 | 0 | 177,317 | 106.1 K to 177.3 K (+67.17 %) |
| Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Option Exercise | A | 42.65 | 10,400 | 443,560 | 10,400 | |
| Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Option Exercise | A | 42.65 | 6,496 | 277,054 | 6,496 | |
| Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Grant | A | 0.00 | 3,914 | 0 | 3,914 | 0 to 3.9 K |